intestinal microbiota metabolism of l-carnitine

intestinal microbiota metabolism of l-carnitine Simplified model for the interaction production pathway γ-Butyrobetaine Is a Proatherogenic Intermediate

Name: intestinal microbiota metabolism of l-carnitine Simplified model for the interaction production pathway γ-Butyrobetaine Is a Proatherogenic Intermediate
Brand: iglepidom.org
SKU: 7884226658
Price: 29.39 USD
Availability: InStock
Rating: 4.2709 (30 reviews)

Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism L carnitine metabolism in bacteria. A) Schematic representation of the Download Scientific Diagram Carnitine Metabolite of the month biocrates life sciences gmbh Elucidation of an anaerobic pathway for metabolism of l carnitinederived butyrobetaine to trimethylamine in human gut bacteria PNAS

SKU: 7884226658 · From iglepidom.org

4.3

USD29.39 USD79.39

Pay in 4 interest-free payments of $7.35 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, et al

intestinal microbiota metabolism of l-carnitine Simplified model for the interaction production pathway -Butyrobetaine Is a Proatherogenic Intermediate

Bollrath, J

Xiao X, Zhao F, DuBois DB, Liu Q, Zhang YL, Yao Q, et al

Cimetidine, a competitive inhibitor of OCT2, is approved for peptic ulcers and prevents acute cold allodynia after oxaliplatin injection (Sprowl et al., 2013)